NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $10,000 | -89.4% | 3,017 | -42.5% | 0.00% | -100.0% |
Q3 2021 | $94,000 | -65.4% | 5,248 | -66.9% | 0.00% | -66.7% |
Q2 2021 | $272,000 | +13500.0% | 15,849 | +11553.7% | 0.01% | – |
Q4 2020 | $2,000 | -99.6% | 136 | -99.4% | 0.00% | -100.0% |
Q2 2020 | $489,000 | +270.5% | 21,131 | +192.6% | 0.05% | +42.1% |
Q3 2019 | $132,000 | +1785.7% | 7,222 | +3212.8% | 0.04% | +1166.7% |
Q1 2019 | $7,000 | -30.0% | 218 | +36.2% | 0.00% | 0.0% |
Q3 2018 | $10,000 | -52.4% | 160 | -18.4% | 0.00% | -72.7% |
Q1 2018 | $21,000 | +200.0% | 196 | -51.0% | 0.01% | +175.0% |
Q3 2016 | $7,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |